| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/18/2013 | US20130096134 Heterocyclic compounds and their uses |
| 04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
| 04/18/2013 | US20130096122 Fused heterocyclic compounds as ion channel modulators |
| 04/18/2013 | US20130096120 Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases |
| 04/18/2013 | US20130096119 Isoquinolin-3-Ylurea Derivatives |
| 04/18/2013 | US20130096115 Methods for treating autism |
| 04/18/2013 | US20130096095 Small-molecule inhibitors of the androgen receptor |
| 04/18/2013 | US20130096089 Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders |
| 04/18/2013 | US20130096084 Novel heterocyclic compounds as erk inhbitors |
| 04/18/2013 | US20130096083 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same |
| 04/18/2013 | US20130095057 Compounds for the treatment of clostridium difficile-associated disease |
| 04/18/2013 | US20130092903 Heterocyclic compound and organic light-emitting device containing the same |
| 04/18/2013 | CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | CA2851087A1 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| 04/18/2013 | CA2850394A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| 04/18/2013 | CA2849385A1 2-oxo-piperidinyl derivatives |
| 04/18/2013 | CA2848197A1 Protein kinase inhibitors |
| 04/17/2013 | EP2581372A1 Cyanoquinoline derivatives |
| 04/17/2013 | EP2581371A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof |
| 04/17/2013 | EP2581370A1 Crystals of di(arylamino)aryl compound |
| 04/17/2013 | EP2581366A1 Renin Inhibitors |
| 04/17/2013 | EP2581365A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode |
| 04/17/2013 | EP2580211A1 Process for the preparation of dihydropyrrole derivatives |
| 04/17/2013 | EP2580208A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 04/17/2013 | EP2580207A1 Nitrogen containing heteroaryl compounds |
| 04/17/2013 | EP2580206A2 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof |
| 04/17/2013 | EP2580205A1 Crystalline forms of thalidomide and processes for their preparation |
| 04/17/2013 | EP2580196A1 Anti-inflammatory agents |
| 04/17/2013 | EP2579873A1 Novel prolylcarboxypeptidase inhibitors |
| 04/17/2013 | EP2579716A1 Novel prolylcarboxypeptidase inhibitors |
| 04/17/2013 | CN103052633A Amids Substituted Indazole Derivativees As Ploy(adp-ribose)polymerase Inhibitors |
| 04/17/2013 | CN103052628A Insecticidal triazines and pyrimidines |
| 04/17/2013 | CN103052627A Pyrimidine derivatives as fak inhibitors |
| 04/17/2013 | CN103044405A Functionalized polyion liquid and metal luminescent material thereof |
| 04/17/2013 | CN103044404A Dabigatran derivatives, and preparation method and application thereof in antithrombosis |
| 04/17/2013 | CN103044403A Preparation method of fasudil hydrochloride |
| 04/17/2013 | CN103044402A Method for synthesizing esomeprazole sodium |
| 04/17/2013 | CN103044401A Preparation method of benzimidazole compound |
| 04/17/2013 | CN103044400A Esomeprazole magnesium salt and preparation method thereof |
| 04/17/2013 | CN103044399A Preparation method of rabeprazole and sodium salts thereof |
| 04/17/2013 | CN103044398A Crystal form of alfentanil hydrochloride |
| 04/17/2013 | CN103044397A New method for synthesizing besifloxacin |
| 04/17/2013 | CN103044396A Preparation method of imatinib mesylate alpha-form crystal |
| 04/17/2013 | CN103044395A Desloratadine-containing amino acid derivative as well as preparation method and application thereof |
| 04/17/2013 | CN103044394A Phenyl aminopyrimidine derivant and preparation method and application thereof |
| 04/17/2013 | CN103044393A Synthesis method of 1-(3-chloro-2-pyridyl)-1H-pyrazole-5-formate |
| 04/17/2013 | CN103044392A Preparation method of high-efficient DPP (dipeptidyl peptidase)-IV inhibitor |
| 04/17/2013 | CN103044391A High-efficient DPP (dipeptidyl peptidase)-IV inhibitor |
| 04/17/2013 | CN103044310A Indoline-3-acetic acid derivative and preparation method thereof as well as application of derivative in medicine |
| 04/17/2013 | CN103040824A Signal channel inhibiting agent as well as preparation method and application thereof |
| 04/17/2013 | CN102512380B Freeze-dried powder injection with omeprazole sodium as active component and preparation method thereof |
| 04/17/2013 | CN102408409B Preparation and fungicidal activity of 3-(1H-imidazole-1-yl)quinoline derivative |
| 04/17/2013 | CN102225932B (Z) type divalent nitenpyram derivatives as well as preparation method and application thereof |
| 04/17/2013 | CN102206202B Pyridazinone derivative and synthetic method thereof |
| 04/17/2013 | CN102093335B Acylhydrazone and hydrazide derivatives and application thereof |
| 04/17/2013 | CN102020635B Preparation method of hydrochloride Fasudil hemihydrate |
| 04/17/2013 | CN101925584B Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis B, hepatitis C, HIV, HPV, bacterial infections and dermatosis |
| 04/17/2013 | CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors |
| 04/17/2013 | CN101597278B Amide-type compound as well as preparation method and application thereof |
| 04/17/2013 | CN101553483B 2-(piperidin-4-yl)-4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
| 04/17/2013 | CN101466670B Inhibitors of histone deacetylase |
| 04/17/2013 | CN101389622B Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 04/17/2013 | CN101166732B Cyanopyridine derivative and use thereof as medicine |
| 04/16/2013 | US8420824 Substituted pyrazoles, compositions containing these, method of production and use |
| 04/16/2013 | US8420823 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient |
| 04/16/2013 | US8420822 Optical resolution of substituted 2-(2-pyridinylmethylsulphinyl)-1H-benzimidazoles |
| 04/16/2013 | US8420813 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| 04/16/2013 | US8420811 Tetrahydroisoquinolines and intermediates therefor |
| 04/16/2013 | US8420675 Aminotetrahydroindazoloacetic acids |
| 04/16/2013 | US8420672 Solid forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindo1-2-yl)-piperidine-2,6-dione and methods of making the same |
| 04/16/2013 | US8420661 Arylethynyl derivatives |
| 04/16/2013 | US8420656 Substituted 5-fluoro-1H-pyrazolopyridines and their use |
| 04/16/2013 | US8420653 Pyrimidine compounds and their uses |
| 04/16/2013 | US8420643 Compounds and method for treatment of cancer |
| 04/16/2013 | US8420642 Pyridine derivatives useful as glucokinase activators |
| 04/16/2013 | US8420641 Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives |
| 04/16/2013 | US8420639 Arylsulfonamide CCR3 antagonists |
| 04/16/2013 | US8420632 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics |
| 04/16/2013 | US8420631 Serotonin receptor antagonist; therapy for obesity, antidepressants, obsessive-compulsive disorders |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420628 Substituted beta-lactams |
| 04/16/2013 | US8420145 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 04/16/2013 | CA2749579C 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester-methanesulphonate and use thereof as a medicament |
| 04/16/2013 | CA2723494C 2-methyl piperazine derivatives for treatment of serotonin-related disorders |
| 04/16/2013 | CA2643170C Sterically hindered amine ethers as stabilizers against light, oxygen and/or heat |
| 04/16/2013 | CA2637204C Substituted quinolones iii |
| 04/16/2013 | CA2553887C Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide |
| 04/16/2013 | CA2548273C Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/16/2013 | CA2491193C Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules |
| 04/16/2013 | CA2486157C Opioid and opioid-like compounds and uses thereof |
| 04/16/2013 | CA2484512C Treatment of cataracts and other ophthalmic diseases |
| 04/11/2013 | WO2013052394A1 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors |
| 04/11/2013 | WO2013052393A1 3-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS |
| 04/11/2013 | WO2013052391A1 PHENYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (Syk) INHIBITORS |
| 04/11/2013 | WO2013052369A1 Novel benzimidazole derivatives |
| 04/11/2013 | WO2013051883A2 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013050987A1 Carbamate/ urea derivatives containing piperidin and piperazin rings as h3 receptor inhibitors |
| 04/11/2013 | WO2013050454A1 Ethynyl derivatives as mglur5 allosteric modulators |